Loading...
Rituximab for the Treatment of Relapses in ANCA-associated Vasculitis
INTRODUCTION: Disease relapses are frequent in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). We evaluated the outcomes of patients re-treated with rituximab (RTX) and prednisone for severe disease relapses. METHODS: The Rituximab in AAV trial was a randomized, double-blind,...
Na minha lista:
| Udgivet i: | Arthritis Rheumatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4229846/ https://ncbi.nlm.nih.gov/pubmed/25047592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38788 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|